• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Moving forward from drug-centred to patient-centred research: A white paper initiated by EORTC and developed together with the BioMed Alliance members.

作者信息

Lacombe Denis, O'Morain Colm, Casadei Barbara, Hill Kate, Mateus Elsa, Lories Rik, Brusselle Guy

机构信息

Director General, European Organisation for Research and Treatment of Cancer.

Past President, Alliance for Biomedical Research in Europe and United European Gastroenterology.

出版信息

Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01870-2018. Print 2019 Feb.

DOI:10.1183/13993003.01870-2018
PMID:30792235
Abstract
摘要

相似文献

1
Moving forward from drug-centred to patient-centred research: A white paper initiated by EORTC and developed together with the BioMed Alliance members.从以药物为中心的研究转向以患者为中心的研究：一份由欧洲癌症研究与治疗组织发起并与生物医学联盟成员共同撰写的白皮书。
Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01870-2018. Print 2019 Feb.
2
Person-centred type 2 diabetes care: time for a paradigm shift.以患者为中心的2型糖尿病护理：是时候进行范式转变了。
Lancet Diabetes Endocrinol. 2018 Apr;6(4):264-266. doi: 10.1016/S2213-8587(17)30193-6. Epub 2017 Jun 9.
3
Where is the person in precision medicine?精准医学中的人在哪里？
J Eval Clin Pract. 2015 Dec;21(6):1022-3. doi: 10.1111/jep.12456. Epub 2015 Sep 22.
4
Summary of the SRNT treatment network Webinar: getting SMART about developing individualized sequences of health interventions.SRNT治疗网络网络研讨会总结：制定个性化健康干预序列要明智行事。
Nicotine Tob Res. 2014 Feb;16(2):252. doi: 10.1093/ntr/ntt197. Epub 2013 Dec 3.
5
Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.美国国立癌症研究所资助的研究人员发起的I期和II期抗癌药物开发的最新创新成果。
Jpn J Clin Oncol. 2015 Nov;45(11):1001-6. doi: 10.1093/jjco/hyv144. Epub 2015 Sep 29.
6
Pragmatic trials revisited: applicability is about individualization.再探实用试验：适用性关乎个体化。
J Clin Epidemiol. 2018 Jul;99:164-166. doi: 10.1016/j.jclinepi.2018.02.003. Epub 2018 Feb 9.
7
Person-centred medicine and mental health.以患者为中心的医学与精神卫生。
Epidemiol Psychiatr Sci. 2012 Jun;21(2):131-7. doi: 10.1017/S204579601200008X.
8
[The relevance of head-to-head trials to patient-centred clinical research].[头对头试验与以患者为中心的临床研究的相关性]
Z Evid Fortbild Qual Gesundhwes. 2011;105(9):639-45. doi: 10.1016/j.zefq.2011.10.028. Epub 2011 Nov 16.
9
Establishing treatment optimisation as part of personalised medicine development.将治疗优化确立为个性化医疗发展的一部分。
Eur J Cancer. 2019 May;113:96-97. doi: 10.1016/j.ejca.2019.03.014. Epub 2019 Apr 15.
10
Precision medicines need precision patient assistance programs.精准医疗需要精准的患者援助计划。
Am J Manag Care. 2019 Jul;25(7):317-318.

引用本文的文献

1
A mixed-methods approach exploring acceptability and feasibility of trials designed to test drugs targeting prevention of post-traumatic osteoarthritis after knee injury.一种混合方法，用于探索旨在测试针对预防膝关节损伤后创伤后骨关节炎的药物的试验的可接受性和可行性。
Bone Joint Res. 2024 Sep 19;13(9):513-524. doi: 10.1302/2046-3758.139.BJR-2024-0109.
2
Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance.数字测量开发中的以患者为中心：最佳实践与监管指南的共同演变
NPJ Digit Med. 2024 May 16;7(1):128. doi: 10.1038/s41746-024-01110-y.
3
A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH).
以患者为中心、多利益相关者共同设计的观察性前瞻性研究方案：以 X 连锁低磷血症（XLH）治疗青少年体验为例。
PLoS One. 2024 Jan 19;19(1):e0295080. doi: 10.1371/journal.pone.0295080. eCollection 2024.
4
Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.分析抗肿瘤治疗的语用标记试验的特点和实用主义程度。
BMC Med Res Methodol. 2023 Jun 24;23(1):148. doi: 10.1186/s12874-023-01975-9.
5
Patient Willingness to Use Digital Health Technologies: A Quantitative and Qualitative Survey in Patients with Cancer Cachexia.癌症恶病质患者使用数字健康技术的意愿：一项定量和定性调查
Patient Prefer Adherence. 2023 Apr 27;17:1143-1157. doi: 10.2147/PPA.S396347. eCollection 2023.
6
Is Efficacy of Tezepelumab Independent of Severe Asthma Phenotype?tezepelumab的疗效是否独立于重度哮喘表型？
Am J Respir Crit Care Med. 2023 Apr 19;208(1):1-3. doi: 10.1164/rccm.202304-0700ED.
7
Practices of patient engagement in drug development: a systematic scoping review.患者参与药物研发的实践：一项系统的范围综述。
Res Involv Engagem. 2022 Jun 29;8(1):29. doi: 10.1186/s40900-022-00364-8.
8
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.过去、现在和未来的癌症临床研究合作：以欧洲癌症研究与治疗组织为例。
Clin Transl Sci. 2021 Jan;14(1):47-53. doi: 10.1111/cts.12863. Epub 2020 Aug 29.
9
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making.欧洲药物研发利益相关者对治疗优化及其在决策中应用潜力的看法。
Front Pharmacol. 2020 Feb 5;11:43. doi: 10.3389/fphar.2020.00043. eCollection 2020.
10
The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer Care.肿瘤学数据网络（ODN）：一个协作式的欧洲数据共享平台，旨在为癌症护理提供信息。
Oncologist. 2020 Jan;25(1):e1-e4. doi: 10.1634/theoncologist.2019-0337. Epub 2019 Sep 5.